CAS: 202850-01-9
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Dodecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]- REF: AN-AG0028HWCAS: 202850-01-9 | 98% | 671,00 € | Jue 16 May 24 | |
C12 NBD-Ceramide REF: 48-39-5051CAS: 202850-01-9 | >98% | A consultar | Mar 21 May 24 | |
C12 NBD-Ceramide REF: 3D-CIA85001CAS: 202850-01-9 | Min. 95% | A consultar | Jue 27 Jun 24 |
Dodecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
CAS:202850-01-9
Fórmula:
C36H61N5O6
Pureza:
98%
Peso molecular:
659.8994
Ref: AN-AG0028HW
1mg | 671,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
Ref: 48-39-5051
1mg | 240,00 € | |
100µg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
C12 NBD-Ceramide
CAS:202850-01-9
Please enquire for more information about C12 NBD-Ceramide including the price, delivery time and more …
Fórmula:
C36H61N5O6
Pureza:
Min. 95%
Peso molecular:
659.9 g/mol
Ref: 3D-CIA85001
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 27 de Junio de 2024